# Beijing ACCB Biotech Company

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-accb-biotech-company

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.accb.com
- Total disclosed funding: $0.4M
- Latest round: Series C (Apr 7, 2017)
- Investors on record: 9

## About

Beijing ACCB Biotech Company Limited is a financial planning and investment services firm dedicated to helping clients achieve their financial objectives through tailored strategies and expert advisory.Founded in 2004, Beijing ACCB Biotech Company Limited, headquartered in Beijing, China, specializes in financial services and investment planning. The company has completed a total of 6 deals, with the most recent deal occurring on April 7, 2017. Notable investors in their funding rounds include Lotus Lake Capital. The firm was founded by Biao He, with Junpu Xu currently serving as CEO. The firm raised CNY 2.4 mn in its latest round, a Seed round, which contributed to a total amount raised of CNY 2.4 mn.ACCB.com specializes in financial planning and investment services that empower individuals and businesses to achieve their financial goals. Their core offerings include comprehensive financial planning tools and investment advisory services focused on diversification strategies across asset classes such as stocks, bonds, mutual funds, and real estate. The company caters to a diverse clientele, including individual investors and corporations, primarily in North America and Europe, providing expert market analysis and economic forecasts to optimize investment strategies.ACCB.com generates revenue through subscription-based financial advisory services and one-time consultation fees from clients on a contractual basis. Their revenue structure includes fees for tailored investment strategies and market analysis reports aimed at navigating complex financial landscapes, serving both B2B and B2C markets with a stable revenue flow throughout the fiscal year.Beijing ACCB Biotech Company Limited is planning to introduce new financial products aimed at enhancing client engagement in the upcoming fiscal year. They are also targeting expansion into new markets in Asia and Europe by 2019. The recent CNY 2.4 mn raised during the Seed round will be allocated toward product development and market entry initiatives to support these growth strategies.

## Funding rounds

- Series C, Apr 7, 2017 — Lotus Lake Capital, Summitview Capital, Renhe Capital, PICC Private Equity Management Co., Ltd., Blue Peninsula Capital
- Series B, Oct 1, 2016 — THG Ventures
- Seed, Dec 1, 2015, $0.4M — Lotus Lake Capital
- Series A, Aug 1, 2014 — SAIF Partners, CoStone Capital
- Angel, Mar 1, 2010 — In Capital

## Investors

- In Capital — Angel
- SAIF Partners (https://capitalatlas.ai/funds/saif-partners) — Series A
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series A
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Seed, Series C
- THG Ventures (https://capitalatlas.ai/funds/thg-ventures) — Series B
- Summitview Capital (https://capitalatlas.ai/funds/summitview-capital) — Series C
- Renhe Capital (https://capitalatlas.ai/funds/renhe-capital) — Series C
- PICC Private Equity Management Co., Ltd. — Series C
- Blue Peninsula Capital (https://capitalatlas.ai/funds/blue-peninsula-capital) — Series C